Clinical Trials · NCT04140409
Sandostatin (Octreotide LAR) May Lead to Clinical Improvement Through Receptor Occupation Optimisation
- Phase
- Phase 4
- Recruitment status
- Terminated
- Sponsor
- Cliniques universitaires Saint-Luc- Université Catholique de Louvain
- Enrollment
- 10
- Start date
- Feb 2016
- Locations
- See registry
- Primary endpoint
- Treatment succes vs treatment failure